Casandra
Casandra Test Code PG82874Version 1 (DRAFT)
Performing Lab
Strabismus Syndrome or Congenital Fibrosis of Extraocular Muscles (Ocular Motility Disorder) Panel
Clinical Use
Order TestUse
This test is designed for individuals with clinical or suspected diagnosis of a strabismus syndrome and those exhibiting features indicative of congenital fibrosis of extraocular muscles (CFEOM) or Duane retraction syndrome (DRS).
Special Instructions
Not provided.
Limitations
This test has not been cleared or approved by the US Food and Drug Administration. It is developed and validated following CAP and CLIA regulations. Testing must be ordered by a qualified Healthcare Provider and clinical information must be included for variant interpretation.
Test Details
New York Approved
Methodology
NGS (Targeted)
Biomarkers
NGS with CNV (Exome or Genome Platform) • Targeted
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided